Rare diseases
Investigational molecules
Locations
Back to France785 clinical trials in Chambery, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on the Safety and Effects of [177Lu]-NeoB in Patients with Advanced Solid Tumors Overexpressing GRPR
FranceStudy on Inclisiran and Rosuvastatin for Lowering Cholesterol in Patients with High Cholesterol Levels
FranceStudy of SEL120 Monohydrochloride for Treating Anemia in Patients with Lower-Risk Myelodysplastic Syndromes (MDS)
FranceStudy on the Effectiveness and Safety of Ianalumab for Patients with Active Sjögren’s Syndrome
FranceStudy Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with High-Risk HER2-Positive Breast Cancer with Residual Disease After Initial Treatment
FranceStudy on Apixaban for Patients with Intrahepatic Non-Cirrhotic Portal Hypertension
FranceStudy Comparing Adagrasib and Docetaxel for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation
FranceStudy on the Safety and Effectiveness of Crinecerfont for Adults with Classic Congenital Adrenal Hyperplasia
FranceStudy on Golcadomide and R-CHOP Drug Combination for Patients with Untreated High-risk Large B-cell Lymphoma
FranceStudy of ribociclib combined with hormone therapy for patients with early-stage hormone receptor-positive, HER2-negative breast cancer
FranceStudy on Early Temozolomide Treatment for Adults with Glioblastoma
FranceStudy on Vemurafenib for Patients with Advanced Cancers with BRAF Gene Changes
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on multiple myeloma and various lymphomas, evaluating novel therapeutic combinations and treatment strategies.
Advanced trials exploring combinations of immunotherapy and targeted treatments for blood cancers.
Studies examining innovative treatments for non-small cell lung cancer, particularly focusing on immunotherapy approaches.
Emphasis on improving treatment outcomes through targeted and combination therapies.
Research on pneumococcal vaccines and preventive treatments, including studies in specialized patient populations.
Focus on vaccine effectiveness during acute illness conditions.
Clinical trials examining treatments for hormone-sensitive breast cancer, including targeted therapies and hormone treatment optimization.
Investigation of personalized treatment approaches based on molecular markers.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
